AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
5.03
-0.08 (-1.57%)
At close: Feb 27, 2026, 4:00 PM EST
5.07
+0.04 (0.80%)
After-hours: Feb 27, 2026, 4:17 PM EST

AVITA Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
154106338352166299
Market Cap Growth
-32.45%-68.69%-4.00%111.74%-44.28%-41.54%
Enterprise Value
18212733929579190
Last Close Price
5.033.4512.8013.726.6011.98
PS Ratio
2.151.485.267.034.839.04
PB Ratio
--6.3675.177.181.962.85
P/TBV Ratio
---7.251.972.87
EV/Sales Ratio
2.541.785.285.882.305.77
Debt / Equity Ratio
-2.77-2.7710.220.870.010.02
Net Debt / Equity Ratio
-1.67-1.672.25-0.95-1.01-0.99
Net Debt / EBITDA Ratio
-0.69-0.69-0.181.113.174.23
Net Debt / FCF Ratio
-0.86-0.86-0.171.184.375.57
Asset Turnover
1.051.050.670.480.32-
Inventory Turnover
1.801.801.412.022.84-
Quick Ratio
0.440.442.377.357.869.70
Current Ratio
0.570.572.837.888.1810.07
Return on Equity (ROE)
---230.96%-52.89%-28.16%-
Return on Assets (ROA)
-39.06%-39.06%-36.97%-25.40%-16.05%-
Return on Capital Employed (ROCE)
676.80%676.80%-95.00%-43.30%-31.40%-23.50%
Earnings Yield
-31.53%-45.89%-18.29%-10.04%-16.03%-8.42%
FCF Yield
-20.90%-30.41%-17.18%-11.18%-11.75%-6.20%
Buyback Yield / Dilution
-7.64%-7.64%-2.18%-1.32%-2.64%-7.42%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q